Qiagen Subsidiary SABiosciences Expands RT2 Profiler PCR Arrays
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
SABiosciences, a QIAGEN company, launches several new RT2 Profiler PCR Arrays for gene expression profiling in nephrotoxicity, hepatotoxicology, differentiation and embryonic stem cells markers as well as analysis of epigenetic modulators and enzymes. Covering more than 100 pathways, PCR arrays enable scientists to easily and accurately analyze the gene expression in research areas such as cancer, stem cells, biomarker discovery and immunology.
The RT2 Profiler PCR Array provides gene expression data from the RNA within three hours and is composed of PCR Array plates, RT2 first strand kit, RT2 SYBR Green Master Mix and the free PCR Array data analysis software. The arrays, originally developed by SABiosciences, make expression profiling accessible for routine use in every lab with a real-time PCR instrument. The experiment is simple to perform and provides sensitive, reproducible, and reliable results to accurately profile multiple genes simultaneously.
The RT2 Profiler PCR Arrays as well as all other products from SABiosciences are now directly available from QIAGEN and offer the most comprehensive portfolio for sample and assay technologies for pathway analysis.
The RT2 Profiler PCR Array provides gene expression data from the RNA within three hours and is composed of PCR Array plates, RT2 first strand kit, RT2 SYBR Green Master Mix and the free PCR Array data analysis software. The arrays, originally developed by SABiosciences, make expression profiling accessible for routine use in every lab with a real-time PCR instrument. The experiment is simple to perform and provides sensitive, reproducible, and reliable results to accurately profile multiple genes simultaneously.
The RT2 Profiler PCR Arrays as well as all other products from SABiosciences are now directly available from QIAGEN and offer the most comprehensive portfolio for sample and assay technologies for pathway analysis.
